Report Industry Investment Rating - Not provided Core Viewpoints - The secondary IG market in Japan faced pressure due to heavy supply, with new issues widening and perpetuals under pressure. Chinese IG also widened, while some Chinese property and Macau gaming bonds showed mixed performance. Fosun's new bond issuance and tender offer are part of its debt management, and its credit profile is improving [2][8][11] Summary by Relevant Catalogs Trading Desk Comments - Yesterday, there were 6 Japanese and 1 Indian bond in the IG new issuance pipeline, pressuring the Japanese secondary IG market. New issues like JERA/HOKKEL/MITSCO widened 2 - 4bps, and perpetuals were pressured by the bear - steepening USD yield curve. Japanese insurance hybrids/AT1s and Yankee AT1s/insurance hybrids declined. China IG widened 2 - 4bps, with better selling on TMT names. Some bonds like FOSUNI 26 - 28s and DALWAN 11 02/13/26 rose. In Chinese properties and Macau gaming, bonds had mixed performance. TW lifers tightened, Korea IG widened, and SEA space had various movements [2] - This morning, new bonds like MUFG 31 - 36/MUFG 6.35 Perp had different price changes. FOSUNI 6.8 09/09/29 was 0.3pt higher, and ADANEM 30 - 31s were 0.2 - 0.5pt higher [3] - In the LGFV space, there was a mixed two - way session with more selling, and bonds repriced 30 - 50bps wider from YTD tights [4] - The top performers included BIMLVN 7 3/8 05/07/26 with a 1.3 price increase, while top underperformers like GLPSP 4 1/2 PERP dropped 2.3 [5] Macro News Recap - On Tuesday, S&P (-0.69%), Dow (-0.55%), and Nasdaq (-0.82%) were lower. US Aug'25 S&P Global Manufacturing PMI was 53.0 (lower than expected), and ISM Manufacturing PMI/Prices were 48.7/63.7 (lower than expected). UST yield was higher, with 2/5/10/30 - year yields at 3.66%/3.74%/4.28%/4.97% [7] Desk Analyst Comments - Analysts are neutral on the new FOSUNI 6.8 09/09/29. Fosun priced the bond at 6.8% (vs IPT of 7.2%), with an issue size capped at USD400mn on an order book over USD2.5bn. The bond has a 4 - year tenor with a 2.5 - year non - call period. Analysts view its valuation as fair, and for Chinese HY, they prefer BTSDF 9.125 07/24/28 and EHICARs [8] - Fosun announced a tender offer for USD500mn FOSUNI 5 05/18/26, to be financed by the new bond issue and/or internal resources. The offer expires on 10 Sep'25 4pm (GMT) and will be settled around 16 Sep'25. Participation in the tender offer doesn't provide priority allocation for the new bond [9] - The new issuance and tender offer are part of Fosun's debt maturity management. In 2025, Fosun has repurchased bonds via tender offers and called the remaining amount. As of Jun'25, it held RMB16bn cash and RMB89.2bn total debt at holdco level, with a plan to deleverage further [10] - Fosun's credit profile is improving due to asset disposals, debt maturity management, and better access to funding channels onshore and offshore. It has issued bonds and raised loans in 2024 - 2025 [11] Offshore Asia New Issues (Priced) - Multiple issuers including Arab National Bank, Ares Capital, Credit Agricole, etc., have priced new bonds with different sizes, tenors, coupons, and issue ratings [12] Offshore Asia New Issues (Pipeline) - Fubon Life, PTT Global Chemical, and Sumitomo Life Insurance have bonds in the issuance pipeline with specified tenors, pricing, and issue ratings [13] News and Market Color - Yesterday, 37 onshore credit bonds were issued with an amount of RMB25bn. Month - to - date, 99 credit bonds were issued, raising RMB68bn, a 10.8% yoy decrease. NIO's 2Q25 revenue rose 9% yoy to RMB19bn. India regulator approved SMBC's acquisition of 20% shareholding in YES Bank, and the US revoked TSMC waiver for shipping chipmaking tools to China [14]

Core Insights - The report highlights a mixed performance in global markets, with notable declines in major indices such as the Hang Seng Index and the S&P 500, while some sectors like energy and healthcare showed resilience [1][3]. - The report indicates a significant increase in private equity research visits in August, particularly in sectors like healthcare and electronics, suggesting growing investor interest [3]. - The report emphasizes the competitive landscape for NIO, projecting a potential net loss of 7.8 billion yuan in 2026 despite a 45% increase in sales, indicating high operational challenges [6]. Company Analysis NIO Inc. (NIO US/9866 HK) - NIO's Q2 2025 revenue grew by 58% to 19 billion yuan, exceeding expectations due to higher average selling prices and R&D service contributions [4]. - The company is expected to narrow its net loss significantly in Q4 2025, with a projected non-GAAP net loss of 1 billion yuan, contingent on achieving a sales volume of 150,000 units and maintaining a gross margin of 16-17% [5]. - Despite optimistic sales forecasts, the report expresses skepticism about NIO's ability to achieve a 20% gross margin due to aggressive pricing strategies [5][6]. ZTE Corporation (763 HK/000063 CH) - ZTE reported a 15% year-on-year revenue increase to 71.6 billion yuan in H1 2025, driven by strong sales in AI infrastructure [6]. - The company’s operating segments showed varied performance, with the enterprise business growing by 110%, primarily due to a surge in server and storage sales [7]. - The report maintains a "Buy" rating for ZTE, raising the target price to 42 HKD, reflecting confidence in its growth trajectory amid the AI investment cycle [6]. Market Observations - The report notes a general decline in major stock indices, with the Hang Seng Index down 0.47% and the S&P 500 down 0.69%, indicating a cautious market sentiment [1]. - The report highlights the impact of geopolitical factors, such as the depreciation of the Japanese yen and political uncertainties in Japan, which may affect investor confidence [3]. - The report also mentions the rising U.S. Treasury yields, driven by concerns over high government debt levels, which could influence market dynamics and investor behavior [3].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 173 RMB, down from the previous target of 176 RMB, indicating a potential upside of 19.1% from the current price of 145.20 RMB [1][2][17]. Core Insights - The company reported a robust performance in the first half of 2025, with revenue increasing by 15% year-on-year to 14 billion RMB, driven by double-digit growth in simulation solutions (+21%) and distribution business (+42%) [1]. - Gross margin remained stable at 30.5%, up 1.3 percentage points year-on-year, while net profit surged by 48% to 2 billion RMB, leading to a net profit margin increase to 14.5% from 11.3% in the same period last year [1]. - The core business, CIS (image sensors), achieved record sales of 10.3 billion RMB, growing 11% year-on-year, with significant growth in automotive (+30%), security (+17%), emerging IoT (+249%), and medical CIS (+68%), offsetting a decline in mobile CIS (-19%) [1][6]. - The company is expected to maintain a favorable position in the CIS market, particularly in automotive and medical sectors, with projected revenue growth of 18% and 25% for FY25 and FY26, respectively, and net profit growth of 24% and 50% [1][6]. Financial Summary - The company’s market capitalization is approximately 172.79 billion RMB, with an average trading volume of 2.1 million RMB [2]. - The financial outlook includes projected sales revenue of 30.3 billion RMB for FY25, with a year-on-year growth of 17.8%, and net profit expected to reach 4.13 billion RMB, reflecting a 24.3% increase [7][11]. - The report indicates a decrease in profit forecasts for FY25 and FY26 by 19% and 15%, respectively, due to slower growth in mobile CIS and pressure on gross margins [6][11].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The company reported strong Q2 2025 results with record-high sales and improved profit margins, particularly in its core PCB business. Revenue reached 5.7 billion RMB, marking a 30% year-over-year and 19% quarter-over-quarter increase, exceeding Bloomberg consensus estimates by 6%. Net profit was 869 million RMB, up 43% year-over-year and 77% quarter-over-quarter, surpassing Bloomberg estimates by 41%. The gross margin improved by 2.8 percentage points to 27.6%, while the net margin reached a historical high of 15.5% [1] - The company's strategic positioning in high-growth sectors such as AI servers, data centers, and automotive electronics supports the "Buy" rating. Continuous capacity expansion from projects in Thailand and Nantong, along with stable R&D investment at 6%-7% of sales, will reinforce the company's competitive advantage and long-term growth [1] - The target price has been raised to 235 RMB, reflecting an 18.7% potential upside from the current price of 198 RMB [3] Financial Summary - For FY25E, the company is projected to achieve sales revenue of 22.68 billion RMB, a 26.6% year-over-year increase. The gross margin is expected to be 26.9%, and net profit is forecasted at 3.03 billion RMB, representing a 61.4% increase year-over-year [2][15] - The company’s EPS is expected to rise to 5.91 RMB in FY25E, with a P/E ratio of 33.5 times [2][15] - The company’s market capitalization is approximately 101.55 billion RMB, with a 52-week stock price range of 198.00/67.53 RMB [3][14] Business Segment Performance - The PCB business, accounting for 60% of total sales, achieved revenue of 6.3 billion RMB in the first half of the year, a 29% year-over-year increase. The growth was driven by strong demand in wireless communication infrastructure, data centers, and automotive applications [8] - The packaging substrate segment saw sales of 1.7 billion RMB, a 9% year-over-year increase, but faced margin pressure due to rising raw material costs and capacity ramp-up challenges [8] Market Comparison - The company’s P/E ratio is projected to be higher than the historical average, reflecting the industry's upward cycle momentum. The new target price is based on a 33.7 times P/E for FY26E, which is approximately one standard deviation above the five-year historical average [8]

Investment Rating - The report maintains a "Buy" rating for the company with a target price raised to 460 RMB, reflecting a potential upside of 23.5% from the current price of 372.50 RMB [1][3]. Core Insights - The company reported a revenue of 79 billion RMB for Q2 2025, representing a year-on-year growth of 22%, despite a quarter-on-quarter decline of 3% due to seasonal fluctuations [1]. - The gross margin decreased to 41.3%, down 6.0 percentage points year-on-year and 1.7 percentage points quarter-on-quarter, primarily due to lower profit margins in the electronic components business [1]. - Net profit was 16 billion RMB, showing a year-on-year decline of 2% but a quarter-on-quarter increase of 3%, with a net profit margin improvement to 20.5% [1]. - The company is strategically positioned in the domestic semiconductor equipment market, benefiting from the trend of domestic substitution [1][7]. - Revenue is expected to grow by 32% and 26% year-on-year in 2025 and 2026, respectively [1]. Financial Summary - For FY25E, the company is projected to achieve sales revenue of 39,473 million RMB, with a year-on-year growth of 31.7% [2]. - The gross margin is expected to be 41.8% in FY25E, with net profit projected at 7,297 million RMB, reflecting a year-on-year growth of 29.6% [2]. - The company’s return on equity is forecasted to be 21.2% in FY25E [2]. Market Position and Growth - The company is expected to capture over 5% market share in the domestic semiconductor equipment sector, with total sales exceeding 210 billion RMB for the year [7]. - The company has expanded its product offerings through R&D and acquisitions, including entering the ion implantation equipment market and acquiring a stake in ChipSource [7]. - The sales of semiconductor equipment are anticipated to grow by approximately 50% year-on-year in the first half of 2025 [7]. Valuation Metrics - The target price of 460 RMB is based on a 35x P/E ratio for 2026, aligning with the historical average [7]. - The company’s market capitalization is approximately 268,945 million RMB [3].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price raised to HKD 12.3, reflecting a potential upside of 28.1% from the current price of HKD 9.60 [1][3][7]. Core Insights - The company reported a strong revenue growth of 68% year-on-year, reaching RMB 1.57 billion in the first half of 2025, primarily driven by a significant increase in automotive product solutions, which grew by 250% [1][7]. - Despite a decline in gross margin by 13.7 percentage points due to changes in product mix, the overall gross margin remains high at 65.4% [1][7]. - The company continues to invest heavily in R&D, leading to a slight increase in net loss to RMB 5.2 billion in the first half of the year [1][7]. - The management emphasizes the competitive advantage in the accelerating adoption of assisted driving technologies in China [1][7]. Financial Overview - Revenue projections show a steady increase from RMB 1.55 billion in FY23A to RMB 8.73 billion in FY27E, with year-on-year growth rates of 71.3% in FY23A and 53.6% in FY24A [2][11]. - Gross margin is expected to stabilize above 50% in the long term, with specific forecasts of 63.8% for FY25E and 58.1% for FY26E [2][11]. - The net profit is projected to remain negative in the coming years, with estimates of RMB -6.93 billion in FY25E and RMB -1.96 billion in FY26E [2][11]. Market Position - The company holds a market share of 45.8% in basic assisted driving solutions and 32.4% in overall assisted driving solutions, reinforcing its leadership in the Chinese automotive technology market [1][7]. - The product solutions segment is anticipated to be the core growth engine, with revenue expected to reach RMB 2.1 billion this year, driven by a shift towards higher-value products [7]. Shareholder Structure - Major shareholders include SAIC QIJUN I HLDG LTD with 9.3% and GIL TRUST LIMITED with 8.1% [4]. Stock Performance - The stock has shown strong performance with a 31.3% absolute return over the past month and a 26.8% return over the past three months [5].

Global Market Overview - Major global stock markets showed varied performance, with the Hang Seng Index rising by 2.15% and the Shenzhen Component Index increasing by 0.87% year-to-date [1][2] - The US stock market remained stable, with the Dow Jones and S&P 500 showing no change, while the Nasdaq saw a year-to-date increase of 11.11% [1] - European markets rebounded, with the DAX and CAC showing increases of 0.57% and 0.05% respectively, supported by better-than-expected economic data [3] Company Analysis Kuaishou (1024 HK) - Kuaishou's 2025 conference highlighted positive advancements in AI, e-commerce, and advertising, with a projected global video production market size of approximately $140 billion by 2024 [4] - The company maintains a "Buy" rating with a target price of HKD 84.0, driven by a projected net profit CAGR of 14% from 2025 to 2027 [4] OmniVision Technologies (603501 CH) - OmniVision reported a 15% year-on-year revenue increase to RMB 14 billion for the first half of 2025, with a net profit surge of 48% to RMB 2 billion [4] - The company maintains a "Buy" rating with a target price of RMB 173, supported by strong growth in automotive and medical CIS sectors [4] China Resources Beverage (2460 HK) - China Resources Beverage experienced an 18.5% revenue decline in the first half of 2025, primarily due to a 23% drop in water business revenue [5][6] - The company is undergoing channel reforms and capacity expansion, with expectations for improved performance in 2026, maintaining a "Buy" rating with a target price of HKD 12.85 [5][6] New Hope Service (3658 HK) - New Hope Service reported a 4.3% revenue increase in the first half of 2025, driven by strong performance in property management [8][9] - The company maintains a "Buy" rating with a target price of HKD 2.50, reflecting a slight adjustment in earnings expectations [8][9] China Pacific Insurance (2328 HK) - China Pacific Insurance's net profit for the first half of 2025 increased by 32.3% to RMB 24.5 billion, driven by underwriting profit and investment income [10] - The company maintains a "Buy" rating with a target price of HKD 21.6, supported by a robust combined ratio of 94.8% [10][11] Alibaba (BABA US) - Alibaba's revenue for the first quarter of FY26 was RMB 247.7 billion, a 1.8% year-on-year increase, with cloud business revenue growth of 26% [12][13] - The company maintains a "Buy" rating with a target price of USD 158.80, reflecting positive developments in cloud and instant retail businesses [12][13] Mindray Medical (300760 CH) - Mindray Medical reported a revenue decline of 18.4% in the first half of 2025, with domestic revenue down 33.4% due to pricing pressures [14][15] - The company maintains a "Buy" rating with a target price of RMB 279.70, anticipating recovery in the second half of 2025 [14][15] Haier Smart Home (6690 HK) - Haier Smart Home expects strong sales growth in the second half of 2025, driven by brand expansion and digital inventory initiatives [16][17] - The company maintains a "Buy" rating with a target price of HKD 31.57, reflecting positive adjustments in profit forecasts [16][17] BYD Electronics (285 HK) - BYD Electronics reported a 4% revenue increase in Q2 2025, driven by growth in the new energy vehicle sector [18] - The company maintains a "Buy" rating with a target price of HKD 47.37, supported by multiple growth drivers including Apple foldable devices [18]

1. Report Industry Investment Rating - No information provided on the report industry investment rating 2. Core Viewpoints of the Report - The report provides a comprehensive update on the fixed - income market, including bond price movements, macroeconomic news, and company - specific analyses. It also offers insights into the Chinese economy and makes predictions on future policy adjustments [2][7][20] - In the fixed - income market, different bonds show various price changes, influenced by factors such as market sentiment, company performance, and macroeconomic conditions [2][4] - Regarding the Chinese economy, there are signs of mild reflation in upstream sectors, but the economic growth may face slowdown pressure in Q4 2025, which could lead to demand - side stimulus and supply - side capacity reduction policies [20][23] 3. Summary by Relevant Catalogs 3.1 Trading Desk Comments - Last Friday, recent IG new issues were overall unchanged to 1bp wider. There were buying flows on HOKKEL 4.587 09/04/30 and two - way flows on OCBCSP 4.55 35s. Some bonds widened, tightened, or remained unchanged. In Chinese properties, some bonds were 0.1 - 0.6pt higher. There were selling flows on front - end Chinese banks/leasing names. Korean corps widened, and S&P changed SAMTOT rating outlook to negative. In Japan, there were selling flows on MUFG/NOMURA curves, and Japanese insurance hybrids edged up. In SEA, GLPSP bonds continued to grow [2] - This morning, there were selling flows for HSBC/MIZUHO/SUMIBK 5 - 6yr floaters. PTTGC 51 - 52s and TOPTB 49 were 0.7 - 2pts higher. FAEACO 12.814 Perp was 1.1pts lower. There were buyers for CNH short - term bonds in LGFVs, and ZHOSHK 28 was largely unchanged [4] 3.2 Macro News Recap - Last Friday, S&P (-0.64%), Dow (-0.20%), and Nasdaq (-1.15%) were lower. The US Jul'25 Core PCE Price Index was +0.3% mom/+2.9% yoy, in line with market expectations. UST yield was lower while 10/30 yr UST yield was higher, with 2/5/10/30 yield at 3.59%/3.68%/4.23%/4.92% [7] 3.3 Desk Analyst Comments - Fubon Life proposes to issue 10.25yr USD T2 bond. The fair value of the new FUBON is considered to be T + 95 - 100, adjusted for tenor and new issue premiums compared to its peers. Fubon Life's credit profile is slightly better than CATLIF in terms of profitability and capital strength [8][9][12] - ZHOSHK's credit profile remains solid. Despite the negative gross margin of new car sales in 1H25, it has consistent positive FCF generation, reducing debts, and low near - term refinancing pressure. The report maintains a buy on ZHOSHK 5.98 01/30/28 [17][18] 3.4 China Economy - China's manufacturing PMI edged higher in August, with improvements in production and demand. There is mild reflation in upstream sectors due to the anti - involution campaign. Non - manufacturing PMI picked up as the service sector recovered, but construction extended its weakness. The economic growth may face slowdown pressure in Q4 2025, and the report expects a 10 bps LPR and 50 bps cut, along with possible transfer payment policies [20][21][23] 3.5 Offshore Asia New Issues - There were no offshore Asia new issues priced or in the pipeline today [25][26] 3.6 News and Market Color - Last Friday, 56 credit bonds were issued onshore with an amount of RMB30bn. In Aug'25, 2,193 credit bonds were issued with a total amount of RMB1,833bn, an 8.9% yoy decrease. There are also various company - specific news such as Alibaba's adjusted EBITDA fall, Bank of China's net interest income drop, etc. [27][31]

Investment Rating - The report maintains a "Buy" rating for the company, with a target price raised to 415 RMB, reflecting a 15.6% potential upside from the current price of 354.92 RMB [1][3]. Core Insights - The company reported strong Q2 2025 results, with revenue reaching 8.1 billion RMB, marking a historical high and a year-on-year growth of 36% and a quarter-on-quarter growth of 22%. Net profit surged to 2.4 billion RMB, with a year-on-year increase of 79% and a quarter-on-quarter increase of 52%, exceeding Bloomberg consensus estimates by 28% [1][6]. - Gross margin and net margin reached historical highs of 41.5% and 29.7%, respectively, surpassing market expectations by 5.7 percentage points and 7.2 percentage points [1][6]. - The company announced a first interim dividend of 0.4 RMB per share, enhancing shareholder returns [1]. Financial Performance Summary - For FY25E, the company expects sales revenue of 38.252 billion RMB, representing a year-on-year growth of 60.3% [2][9]. - The gross margin is projected to be 43.0% for FY25E, an increase from previous estimates [6][9]. - Net profit for FY25E is forecasted at 11.691 billion RMB, reflecting a year-on-year growth of 126.1% [2][9]. - The earnings per share (EPS) is expected to be 10.66 RMB for FY25E, with a significant increase from prior years [2][9]. Market Dynamics - The demand for high-performance optical modules is driving revenue growth, with a strong emphasis on 800G and 1.6T product shipments [6]. - The company’s overseas revenue, accounting for 86% of total revenue in the first half of 2025, remains a core growth driver [6]. - The capital expenditure cycle driven by AI is expected to sustain the company's performance, with major cloud providers projected to increase their capital expenditures significantly [6]. Profitability and Margin Expansion - The gross margin for optical modules increased by 6.1 percentage points year-on-year to 40.0%, while the net margin rose by 5.8 percentage points to 29.7% [6]. - The expansion in margins is attributed to a higher proportion of high-margin products and effective supply chain management [6]. - The report anticipates further margin improvement with the large-scale production of 1.6T products in the second half of the year [6].

Investment Rating - The report maintains a "Buy" rating for the company [7][8]. Core Views - The company's revenue for 1H25 increased by 9.5% year-on-year to 1.49 billion RMB, while net profit rose by 41.6% to 150 million RMB, indicating strong performance driven by robust offline demand [1][7]. - The management has adjusted the 2025 revenue growth forecast to 10%-15% from the previous 25%, citing changes in the macro environment [1][7]. - The company is expected to return to a revenue growth rate of over 20% in 2026 [1]. Financial Summary - For FY25E, the company is projected to achieve sales revenue of 3.445 billion RMB, reflecting a year-on-year growth of 14.0% [2][8]. - Adjusted net profit for FY25E is estimated at 460 million RMB, with a growth rate of 15.0% [2][8]. - The adjusted earnings per share (EPS) for FY25E is forecasted to be 1.95 RMB [2][8]. Price Target and Valuation - The target price is set at 48.28 HKD, down from a previous target of 52.75 HKD, representing a potential upside of 48.6% from the current stock price of 32.50 HKD [3][7]. - The discounted cash flow (DCF) valuation indicates a per-share value of 48.28 HKD, based on a weighted average cost of capital (WACC) of 10.2% and a perpetual growth rate of 3.0% [10][11]. Shareholder Structure - The largest shareholder is Tu Zhiliang, holding 34.2% of the shares, followed by Ruiyuan Fund with 8.0% [4]. Stock Performance - The stock has shown a decline in absolute returns over the past month (-8.2%) and three months (-11.6%) [5]. Business Development - The company opened 7 new stores in 1H25, bringing the total to 83, and plans to add approximately 15 more stores in 2025 [7]. - The number of doctors in the network increased by 1,501 in 1H25, with a 23.5% year-on-year growth in offline doctors [7]. AI Initiatives - The company has launched AI initiatives, including the first "Famous Doctor AI Avatar," which is expected to generate significant revenue in the future [7]. Shareholder Returns - In 1H25, the company repurchased shares worth 84.69 million HKD, equivalent to 50% of net profit, and declared a mid-term dividend of 75.77 million RMB, also 50% of net profit [7].